Dingjiu Bao

1.4k total citations
7 papers, 548 citations indexed

About

Dingjiu Bao is a scholar working on Physiology, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Dingjiu Bao has authored 7 papers receiving a total of 548 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Physiology, 3 papers in Molecular Biology and 3 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Dingjiu Bao's work include Liver Disease Diagnosis and Treatment (2 papers), Adipose Tissue and Metabolism (2 papers) and Adenosine and Purinergic Signaling (1 paper). Dingjiu Bao is often cited by papers focused on Liver Disease Diagnosis and Treatment (2 papers), Adipose Tissue and Metabolism (2 papers) and Adenosine and Purinergic Signaling (1 paper). Dingjiu Bao collaborates with scholars based in United States and Germany. Dingjiu Bao's co-authors include Scott C. Thomson, Volker Vallon, Aihua Deng, Sanjay Bhanot, Brett P. Monia, Robert A. McKay, Xing Yu, Susan Kelly, Susan F. Murray and Sheri Booten and has published in prestigious journals such as Journal of Clinical Investigation, Hepatology and Diabetes.

In The Last Decade

Dingjiu Bao

7 papers receiving 539 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dingjiu Bao United States 5 207 170 154 134 125 7 548
Audrey Ayer France 14 298 1.4× 117 0.7× 188 1.2× 79 0.6× 43 0.3× 23 602
Pablo Cabral United States 12 160 0.8× 144 0.8× 142 0.9× 109 0.8× 32 0.3× 23 435
Karim Benkirane Canada 8 364 1.8× 134 0.8× 190 1.2× 61 0.5× 107 0.9× 10 683
Marcos E. Alfie United States 8 152 0.7× 190 1.1× 146 0.9× 29 0.2× 84 0.7× 10 610
Wan Sub Shim South Korea 12 201 1.0× 113 0.7× 130 0.8× 133 1.0× 39 0.3× 22 465
Anu Shah United States 8 268 1.3× 75 0.4× 83 0.5× 63 0.5× 29 0.2× 12 486
Colette M. Knight United States 8 327 1.6× 183 1.1× 456 3.0× 215 1.6× 29 0.2× 9 1.0k
Curtis K. Kost United States 17 207 1.0× 191 1.1× 148 1.0× 26 0.2× 33 0.3× 30 644
May C.M. Yang Taiwan 15 196 0.9× 75 0.4× 153 1.0× 93 0.7× 40 0.3× 32 573
Romina Vargas Chile 13 173 0.8× 73 0.4× 103 0.7× 149 1.1× 88 0.7× 23 478

Countries citing papers authored by Dingjiu Bao

Since Specialization
Citations

This map shows the geographic impact of Dingjiu Bao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dingjiu Bao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dingjiu Bao more than expected).

Fields of papers citing papers by Dingjiu Bao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dingjiu Bao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dingjiu Bao. The network helps show where Dingjiu Bao may publish in the future.

Co-authorship network of co-authors of Dingjiu Bao

This figure shows the co-authorship network connecting the top 25 collaborators of Dingjiu Bao. A scholar is included among the top collaborators of Dingjiu Bao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dingjiu Bao. Dingjiu Bao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Laffitte, Bryan, Paul V. Rucker, D. CHIANELLI, et al.. (2018). LJN452 (tropifexor) attenuates steatohepatitis, inflammation, and fibrosis in dietary mouse models of nonalcoholic steatohepatitis. Journal of Hepatology. 68. S341–S342. 2 indexed citations
2.
Laffitte, Bryan, Dingjiu Bao, Jocelyn Zoll, et al.. (2017). Development of LMB763, a novel, orally bioavailable, clinical farnesoid X receptor agonist for the treatment of non-alcoholic steatohepatitis and hepatobiliary disorders. Journal of Hepatology. 66(1). S166–S166. 3 indexed citations
3.
Alper, Phil B., Mihai Azimioara, Daniel Mutnick, et al.. (2014). Discovery of structurally novel, potent and orally efficacious GPR119 agonists. Bioorganic & Medicinal Chemistry Letters. 24(10). 2383–2387. 9 indexed citations
4.
Yu, Xing, Susan F. Murray, Sanjay K. Pandey, et al.. (2005). Antisense oligonucleotide reduction of DGAT2 expression improves hepatic steatosis and hyperlipidemia in obese mice†. Hepatology. 42(2). 362–371. 231 indexed citations
6.
Thomson, Scott C., Dingjiu Bao, Aihua Deng, & Volker Vallon. (2000). Adenosine formed by 5′-nucleotidase mediates tubuloglomerular feedback. Journal of Clinical Investigation. 106(2). 289–298. 141 indexed citations
7.
Thomson, Scott C., Sebastian Bachmann, M. Bostanjoglo, et al.. (1999). Temporal adjustment of the juxtaglomerular apparatus during sustained inhibition of proximal reabsorption. Journal of Clinical Investigation. 104(8). 1149–1158. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026